Legend Biotech Corporation
LEGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,975 | $5,297 | $3,970 | $3,283 |
| - Cash | $287 | $1,278 | $786 | $689 |
| + Debt | $351 | $329 | $285 | $123 |
| Enterprise Value | $3,039 | $4,348 | $3,468 | $2,717 |
| Revenue | $627 | $285 | $117 | $69 |
| % Growth | 120% | 143.7% | 70% | – |
| Gross Profit | $393 | $141 | $52 | $69 |
| % Margin | 62.6% | 49.4% | 44.1% | 100% |
| EBITDA | -$113 | -$478 | -$417 | -$392 |
| % Margin | -18% | -167.6% | -356% | -570.1% |
| Net Income | -$177 | -$518 | -$446 | -$404 |
| % Margin | -28.2% | -181.8% | -381.5% | -586.4% |
| EPS Diluted | -1.94 | -5.88 | -5.62 | -5.48 |
| % Growth | 67% | -4.6% | -2.6% | – |
| Operating Cash Flow | -$144 | -$393 | -$201 | -$198 |
| Capital Expenditures | -$14 | -$23 | -$22 | -$45 |
| Free Cash Flow | -$158 | -$416 | -$224 | -$244 |